SPI1 and acute myeloid leukemia: A genome-wide gene expression analysis of blasts from AML patients revealed that PU.1 was clearly expressed at a lower level in APL patients as compared to non-APL patients (Figure 2A), indicating that PU.1 expression might be specifically reduced by PML-RARα in APL.